Stocktoria

Palomino Laboratories Inc. PALX

OTC · stock · Semiconductors & Related Devices · website · IPO 2026-04-16

Palomino Laboratories Inc. (PALX) earns a Piotroski F-score of 2/9 (weak financial health). It does not currently pay a dividend.

2/9
Piotroski F — financial health
Altman Z″ — distress risk
Dividend payout · no dividend

How it ranks in Manufacturing · percentile among 1906 companies

Piotroski Fstronger than 12%
Return on equitystronger than 33%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 2/9 tests passed

Sector peers · similar-size Manufacturing companies

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
PALXPalomino Laboratories Inc.2/9
KYOAYKYOCERA CORP5/97.6+10.8%
NVDANVIDIA CORP4/912.8538.8+65.5%
TYGOTIGO ENERGY, INC.6/9-4.06+91.7%
AVGOBroadcom Inc.4/92.64+23.9%
INTCINTEL CORP6/93.24-0.5%
MUMICRON TECHNOLOGY INC7/96.07149.5+48.9%

All Manufacturing companies →

FAQ

Is PALX financially healthy?

Palomino Laboratories Inc.'s Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak).

Does PALX pay a dividend?

No, Palomino Laboratories Inc. does not currently pay a dividend.

How profitable is PALX?

In FY2025, Palomino Laboratories Inc. had a return on equity of -39.1%.

Source: SEC EDGAR filings · CIK 0001938569 · US · as of 2025-12-31. facts plus Stocktoria's own computed scores — not investment advice.